Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes.
+ 2 more risks
Adequate balance sheet with weak fundamentals.
Share Price & News
How has Imagin Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: DPD2's share price has been volatile over the past 3 months.
7 Day Return
DE Medical Equipment
1 Year Return
DE Medical Equipment
Return vs Industry: DPD2 underperformed the German Medical Equipment industry which returned 6.5% over the past year.
Return vs Market: DPD2 underperformed the German Market which returned -20.9% over the past year.
Price Volatility Vs. Market
How volatile is Imagin Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Imagin Medical undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate DPD2's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate DPD2's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: DPD2 is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.
PE vs Market: DPD2 is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DPD2's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DPD2 is overvalued based on its PB Ratio (6.4x) compared to the DE Medical Equipment industry average (5x).
How is Imagin Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Imagin Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Imagin Medical's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Imagin Medical competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Imagin Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DPD2 is currently unprofitable.
Growing Profit Margin: DPD2 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: DPD2 is unprofitable, and losses have increased over the past 5 years at a rate of -37.4% per year.
Accelerating Growth: Unable to compare DPD2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DPD2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.9%).
Return on Equity
High ROE: DPD2 has a negative Return on Equity (-538.45%), as it is currently unprofitable.
How is Imagin Medical's financial position?
Financial Position Analysis
Short Term Liabilities: DPD2's short term assets (CA$1.1M) exceed its short term liabilities (CA$373.4K).
Long Term Liabilities: DPD2 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DPD2 is debt free.
Reducing Debt: DPD2 had no debt 5 years ago.
Inventory Level: DPD2 has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if DPD2's debt is covered by short term assets.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DPD2 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: DPD2 has less than a year of cash runway if free cash flow continues to reduce at historical rates of -42.5% each year
What is Imagin Medical's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DPD2's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate DPD2's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DPD2's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DPD2's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DPD2's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Edward James Hutchens, also known as Jim, is the Co-founder and Managing Director of Origin Partners. Mr. Hutchens has been Chief Executive Officer and President of Imagin Medical Inc. since February 2 ...
CEO Compensation Analysis
Compensation vs Market: Jim's total compensation ($USD459.29K) is about average for companies of similar size in the German market ($USD428.66K).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
|CEO, President & Director||4.17yrs||CA$649.10k||4.51% CA$210.0k|
|CFO, Corporate Secretary & Director||2.25yrs||CA$338.86k||0.17% CA$8.1k|
|Independent Director||1.5yrs||CA$6.00k||0.16% CA$7.3k|
|Chairman of Scientific Medical Advisory Board||4yrs||no data||no data|
|Member of Scientific Medical Advisory Board||3.58yrs||no data||no data|
|Member of Scientific Advisory Board||1yr||no data||no data|
|Independent Chairperson of the Board||no data||CA$6.00k||0.60% CA$27.7k|
|Independent Director||3.58yrs||CA$71.85k||0.16% CA$7.3k|
|Member of Scientific Medical Advisory Board||3.5yrs||no data||no data|
|Member of Scientific Medical Advisory Board||3.42yrs||no data||no data|
Experienced Board: DPD2's board of directors are considered experienced (3.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: DPD2 insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13%.
Imagin Medical Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Imagin Medical Inc.
- Ticker: DPD2
- Exchange: DB
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$7.094m
- Listing Market Cap: CA$4.652m
- Shares outstanding: 177.34m
- Website: https://imaginmedical.com
- Imagin Medical Inc.
- 890 West Pender Street
- Suite 600
- British Columbia
- V6C 1L9
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|DPD2||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Feb 2016|
|IMEX.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Feb 2016|
|IME||CNSX (Canadian National Stock Exchange)||Yes||Common Shares||CA||CAD||Feb 2016|
Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes. Its ultrasensitive imaging technology is based on improved optical designs and advanced light sensors for detecting cancer, as well as visualize, identify, and remove cancerous cells. The company’s target market is bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/04/06 00:03|
|End of Day Share Price||2020/04/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.